SNS-314

· Sunesis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SNS-314, covering 2017-04-04 to 2017-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors [Phase 1]